No CrossRef data available.
Article contents
The Value of Universal versus Targeted Screening for Methicillin-Resistant Staphylococcus aureus among Admission Patients
Published online by Cambridge University Press: 02 January 2015
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
- Type
- Letters to the Editor
- Information
- Copyright
- Copyright © The Society for Healthcare Epidemiology of America 2012
References
1.
Leonhardt, KK, Yakusheva, O, Phelan, D, et al. Clinical effectiveness and cost benefit of universal versus targeted methicillin-resistant Staphylococcus aureus screening upon admission in hospitals. Infect Control Hosp Epidemiol
2011;32:797–803.Google Scholar
2.
Creamer, E, Galvin, S, Dolan, A, et al. Evaluation of screening risk and nonrisk patients for methicillin-resistant Staphylococcus aureus on admission in an acute care hospital. Am J Infect Control doi:10.1016/j.ajic.2011.07.008. Published September 30, 2011.Google Scholar
3.
Dancer, SJ. Considering the introduction of universal MRSA screening. J Hosp Infect
2008;69:315–320.CrossRefGoogle ScholarPubMed
4.
Reilly, JS, Stewart, S, Christie, P, et al. Universal screening for meticillin-resistant Staphylococcus aureus: interim results from the NHS Scotland pathfinder project. J Hosp Infect
2010;74:35–41.CrossRefGoogle ScholarPubMed
5.
Creamer, E, Dolan, A, Sherlock, O, et al. The effect of rapid screening for methicillin-resistant Staphylococcus aureus (MRSA) on the identification and early isolation of MRSA-positive patients. Infect Control Hosp Epidemiol
2010;31:374–381.Google Scholar
6.
Uckay, I, Sax, H, Iten, A, et al. Effect of screening for methicillin-resistant Staphylococcus aureus carriage by polymerase chain reaction on the duration of unnecessary preemptive contact isolation. Infect Control Hosp Epidemiol
2008;29:1077–1079.CrossRefGoogle ScholarPubMed
You have
Access